Amicus Therapeutics Balance Sheet Health
Financial Health criteria checks 3/6
Amicus Therapeutics has a total shareholder equity of $160.2M and total debt of $387.9M, which brings its debt-to-equity ratio to 242.1%. Its total assets and total liabilities are $777.9M and $617.7M respectively.
Key information
242.1%
Debt to equity ratio
US$387.86m
Debt
| Interest coverage ratio | n/a |
| Cash | US$286.20m |
| Equity | US$160.17m |
| Total liabilities | US$617.71m |
| Total assets | US$777.88m |
Recent financial health updates
Amicus Therapeutics (NASDAQ:FOLD) Is Carrying A Fair Bit Of Debt
Jul 06
Does Amicus Therapeutics (NASDAQ:FOLD) Have A Healthy Balance Sheet?
Mar 23We Think Amicus Therapeutics (NASDAQ:FOLD) Has A Fair Chunk Of Debt
Dec 06Amicus Therapeutics (NASDAQ:FOLD) Is Carrying A Fair Bit Of Debt
Aug 25Is Amicus Therapeutics (NASDAQ:FOLD) Weighed On By Its Debt Load?
May 06Recent updates
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Looks Inexpensive But Perhaps Not Attractive Enough
Mar 27Amicus Therapeutics: Expect Improved Commercial Momentum In 2024
Feb 29Amicus Therapeutics, Inc.'s (NASDAQ:FOLD) Share Price Could Signal Some Risk
Dec 19Amicus Therapeutics (NASDAQ:FOLD) Is Carrying A Fair Bit Of Debt
Jul 06Amicus Therapeutics, Inc.'s (NASDAQ:FOLD) Revenues Are Not Doing Enough For Some Investors
May 14Does Amicus Therapeutics (NASDAQ:FOLD) Have A Healthy Balance Sheet?
Mar 23We Think Amicus Therapeutics (NASDAQ:FOLD) Has A Fair Chunk Of Debt
Dec 06Amicus Therapeutics (NASDAQ:FOLD) Is Carrying A Fair Bit Of Debt
Aug 25Amicus Therapeutics: AT-GAA Approval Delayed, I Will Continue Holding
Aug 10Amicus Therapeutics Q2 2022 Earnings Preview
Aug 03Is Amicus Therapeutics (NASDAQ:FOLD) Weighed On By Its Debt Load?
May 06Amicus Therapeutics: An Inflection Point In Growth
Apr 27Amicus: July 29 PDUFA Makes It A Hold
Apr 11Financial Position Analysis
Short Term Liabilities: FOLD's short term assets ($483.1M) exceed its short term liabilities ($167.7M).
Long Term Liabilities: FOLD's short term assets ($483.1M) exceed its long term liabilities ($450.0M).
Debt to Equity History and Analysis
Debt Level: FOLD's net debt to equity ratio (63.5%) is considered high.
Reducing Debt: FOLD's debt to equity ratio has increased from 93.8% to 242.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: FOLD has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if FOLD has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.